“The breakthrough use of IL-6 receptor blockers in patients with severe or critical COVID-19, along with corticosteroids, will only be effective if we can scale up manufacturing & distribute equitably. It’s not charity, it’s the best way to end the acute stage of the pandemic”- Tedros Adhanom Ghebreyesus | World Health Organization (WHO)